FI109695B - Diagnostiska 1,4,7,10-tetraazacyklododekanbutyltrioler, deras användning som diagnostiska medel och förfarande för deras framställning - Google Patents
Diagnostiska 1,4,7,10-tetraazacyklododekanbutyltrioler, deras användning som diagnostiska medel och förfarande för deras framställning Download PDFInfo
- Publication number
- FI109695B FI109695B FI911330A FI911330A FI109695B FI 109695 B FI109695 B FI 109695B FI 911330 A FI911330 A FI 911330A FI 911330 A FI911330 A FI 911330A FI 109695 B FI109695 B FI 109695B
- Authority
- FI
- Finland
- Prior art keywords
- general formula
- group
- metal
- tetraazacyclododecane
- order numbers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
- A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Radiology & Medical Imaging (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Claims (8)
1. Diagnostisk 1,4,7,10-tetraazacyklododekanbutyl-triol kännetecknad av, att den har den allmän-5 na formeln IA, r’oOC__ /---^ R2 H \ ( J 10 1 _A /\ 1 r’ooC-' \_/ -COOR vari vart och ett R1 självständigt betecknar väte eller en met-alljonekvivalent av ett element med ordningstal 21 - 29, 15 42, 44 eller 57 - 83, eller en radionuklid av ett element med ordningstal 27, 29, 31, 32, 37 - 39, 43, 49, 62, 64, 70 eller 77, och R2 betecknar en butyltriolgrupp, samt salterna av dessa föreningar med oorganiska eller or-20 ganiska baser eller aminosyror. ... 2. Förening enligt patentkrav 1, k ä n n e - .'** tecknad av att substituenterna R1 betecknar vätea- • ·’ tomer. • · · ·’ 3. Förening enligt patentkrav 1, kanne- *·’*** 25 tecknad av att minst tvä av R1-substituenterna be-tecknar en metalljonekvivalent av ett element med ordning-stal 21 - 29, 42, 44 eller 57 - 83, eller en radionuklid av ett element med ordningstal 27, 29, 31, 32, 37 - 39, 43, : 49, 62, 64, 70 eller 77. ,···. 30 4. Förening enligt patentkrav 2, känne tecknad av, att den är 10-(2,3,4-trihydroxibutyl)-\i.: 1,4,7-triskarboximetyl-l, 4,7,10-tetraazacyklododekan eller 10- (l-hydroximetyl-2,3-dihydroxipropyl)-1,4,7-triskarboxi-,:. metyl-l, 4,7,10-tetraazacyklododekan. I k » » » 35 29 109695
5. Gadoliniumkomplex kännetecknat av, att det erhällits frän 10-(2,3,4-trihydroxibutyl)-1,4,7-triskarboximetyl-1,4,7,10-tetraazacyklododekan eller 10-(1-hydroximetyl-2,3-dihydroxipropyl)-1,4,7-triskarboximetyl- 5 1,4,7,10-tetraazacyklododekan.
6. Användning av ett metallkomplex med den allmänna formeln IA väri minst tvä R1-substituenter betecknar en met-alljonekvivalent vid NMR-, röntgen-, ultraljuds- och radio-diagnostik. 10 7. Förfarande för framställning av 1,4,7,10- tetraazacyklododekanbutyltriol med den allmänna formeln IA R10OC χ^ VL* /" % 15 ^ nn n r’oOC-S\_/ \-COOR1 väri var och en R1 självständigt betecknar väte eller en metalljonekvivalent av ett element med ordningstal 21 - 29, 20 42, 44 eller 57 - 83, eller en radionuklid av ett element ... med ordningstal 27, 29, 31, 32, 37 - 39, 43, 49, 62, 64, 70 eller 77, och R2 betecknar en butyltriolgrupp, samt sal- • *’ terna av dessa föreningar med oorganiska eller organiska baser eller aminosyror, kännetecknat av att 25 ett förening med den allmänna formeln II * * · I f · K /-\ /H / N N\ (II),
30 W X \_/ x • » · '·,,,· väri X beetcknar en kväveskyddsgrupp eller grupp en grupp -CH2COOY, Y betecknar väte, en ammoniumkatjon, en alkali- > • ( ; 35 metall eller en skyddsgrupp, bringas att reagera pä i och för sig känt sätt med ett gruppen R2 i skyddad form i 30 10969b molekylen införande substrat, eventuellt avlägsnar man de i molekylen ingäende kväveskyddsgrupperna X, och de sälunda frigjorda -NH-grupperna alkyleras med ett ättiksyraderivat med den allmänna formeln III 5 HalCH2COOY (III) vari Hal betecknar klor, brom eller jod, man avlägsnar hydroxi- och eventuellt syraskyddsgrupperna 10 och den erhällna föreningen med den allmänna formeln IA, väri R1 betecknar väte, medelst en metalloxid eller ett metallsalt överföres till ett metallkomplex med den allmänna formeln IA, väri R1 betecknar en metalljonekviva-lent av ett element med ordningstal 21 - 29, 42, 44 eller 15 57 - 83, eller en radionuklid av ett element med ordningstal 27, 29, 31, 32, 37 - 39, 43, 49, 62, 64, 70 eller 77, och därefter, om sä önskas, fortfarande närvarande sura väteatomer substitueras med oorganiska och/eller organiska baser, aminosyror eller aminosyraamider. 20 « · 1 • · 1 • · I ·
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4009119A DE4009119A1 (de) | 1990-03-19 | 1990-03-19 | 1,4,7,10-tetraazacyclododecan-butyltriole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel |
DE4009119 | 1990-03-19 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI911330A0 FI911330A0 (fi) | 1991-03-19 |
FI911330A FI911330A (fi) | 1991-09-20 |
FI109695B true FI109695B (sv) | 2002-09-30 |
Family
ID=6402765
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI911330A FI109695B (sv) | 1990-03-19 | 1991-03-19 | Diagnostiska 1,4,7,10-tetraazacyklododekanbutyltrioler, deras användning som diagnostiska medel och förfarande för deras framställning |
Country Status (17)
Country | Link |
---|---|
US (4) | US5980864A (sv) |
EP (1) | EP0448191B1 (sv) |
JP (1) | JP2968367B2 (sv) |
AT (1) | ATE124405T1 (sv) |
AU (1) | AU647091B2 (sv) |
CA (1) | CA2038493C (sv) |
DE (3) | DE4009119A1 (sv) |
DK (1) | DK0448191T3 (sv) |
ES (1) | ES2074219T3 (sv) |
FI (1) | FI109695B (sv) |
HK (1) | HK1002811A1 (sv) |
HU (1) | HU215964B (sv) |
IE (1) | IE67643B1 (sv) |
IL (1) | IL97592A (sv) |
NO (2) | NO179610C (sv) |
NZ (1) | NZ237461A (sv) |
PT (1) | PT97065B (sv) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5316757A (en) * | 1984-10-18 | 1994-05-31 | Board Of Regents, The University Of Texas System | Synthesis of polyazamacrocycles with more than one type of side-chain chelating groups |
US5362476A (en) * | 1984-10-18 | 1994-11-08 | Board Of Regents, The University Of Texas System | Alkyl phosphonate polyazamacrocyclic cheates for MRI |
DE4035760A1 (de) * | 1990-11-08 | 1992-05-14 | Schering Ag | Mono-n-substituierte 1,4,7,10-tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel |
DE4237943C2 (de) * | 1992-11-06 | 1997-10-23 | Schering Ag | Verfahren zur Herstellung von Metallkomplexen der N-beta-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,7,10-tetraazacyclododecan- und N-beta-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecan-Derivate |
DE4140779A1 (de) * | 1991-12-06 | 1993-06-09 | Schering Ag Berlin Und Bergkamen, 1000 Berlin, De | Verfahren zur herstellung von mono-n-substituierten tetraazamakrocyclen |
DE4218744C2 (de) * | 1992-06-04 | 1997-11-06 | Schering Ag | Verfahren zur Herstellung von N-ß-Hxdroxyalkyl-tri-N-carboxylalkyl-1,4,7,10-tetraazacyclododecan- und N-ß-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecan-Derivaten und deren Metallkomplexe |
DE4317588C2 (de) * | 1993-05-24 | 1998-04-16 | Schering Ag | Fluorhaltige makrocyclische Metallkomplexe, Verfahren zu ihrer Herstellung, sowie ihre Verwendung |
DE4318369C1 (de) * | 1993-05-28 | 1995-02-09 | Schering Ag | Verwendung von makrocyclischen Metallkomplexen als Temperatursonden |
JP3356289B2 (ja) * | 1995-06-26 | 2002-12-16 | コンキャット リミティド | 第一遷移系列元素に対してキレート化親和性および選択性のある化合物とその医療および診断への使用 |
DE19646762B4 (de) * | 1996-11-04 | 2004-05-13 | Schering Ag | Verwendung von Metallverbindungen zur Herstellung von Mitteln zur Strahlentherapie von Tumoren |
DE19652387A1 (de) * | 1996-12-04 | 1998-06-10 | Schering Ag | Macrocyclische Metallkomplexcarbonsäuren, ihre Verwendung sowie Verfahren zu ihrer Herstellung |
US20030017941A1 (en) * | 1997-03-07 | 2003-01-23 | The Procter & Gamble Company | Catalysts and methods for catalytic oxidation |
US20050187126A1 (en) * | 2002-08-27 | 2005-08-25 | Busch Daryle H. | Catalysts and methods for catalytic oxidation |
ZA981883B (en) * | 1997-03-07 | 1998-09-01 | Univ Kansas | Catalysts and methods for catalytic oxidation |
US20080125344A1 (en) * | 2006-11-28 | 2008-05-29 | Daryle Hadley Busch | Bleach compositions |
ATE295408T1 (de) | 1997-03-07 | 2005-05-15 | Procter & Gamble | Bleichmittelzusammensetzungen |
DE19724186C2 (de) * | 1997-06-02 | 2002-07-18 | Schering Ag | Verfahren zur Mono- und 1,7-Bis-N-ß-Hydroxyalkylierung von Cyclen und die entsprechenden N-ß-Hydroxyalkyl-1,4,7,10-tetraazacyclododecan-Li-Salz-Komplexe |
IT1297035B1 (it) | 1997-12-30 | 1999-08-03 | Bracco Spa | Derivati dell'acido 1,4,7,10-tetraazaciclododecan-1,4-diacetico |
DE19816370B4 (de) * | 1998-04-03 | 2004-09-09 | Schering Ag | Substituierte Mangan-D02A-Komplexe, diese enthaltende diagnostische Mittel und ihre Verwendung |
EP1088559A3 (de) * | 1999-09-29 | 2002-10-02 | INSTITUT FÜR DIAGNOSTIKFORSCHUNG GmbH AN DER FREIEN UNIVERSITÄT BERLIN | Galenische Formulierungen |
DE10064467C2 (de) * | 2000-12-15 | 2002-10-31 | Schering Ag | Lithium-Komplexe von N-(1-Hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecan, deren Herstellung und Verwendung |
US7011816B2 (en) * | 2001-12-26 | 2006-03-14 | Immunomedics, Inc. | Labeling targeting agents with gallium-68 and gallium-67 |
WO2004006934A2 (de) * | 2002-07-10 | 2004-01-22 | Hans Robert Kalbitzer | 1,4,7,10-tetraazacyclododecane als modulatoren des guanin-nukleotid bindenden roteins zur behandlung von tumoren |
US20040048763A1 (en) * | 2002-08-27 | 2004-03-11 | The Procter & Gamble Co. | Bleach compositions |
US20060239913A1 (en) * | 2003-06-25 | 2006-10-26 | Marc Port | Peptide conjugate for magnetic resonance imaging |
FR2867473B1 (fr) | 2004-03-12 | 2006-06-23 | Guerbet Sa | Compose de porphyrines et utilisation a haut champ en irm |
WO2006002874A1 (en) * | 2004-07-02 | 2006-01-12 | Bracco Imaging Spa | Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain 1, 4, 7, 10-tertraazacyclodecan-1, 4, 7-triacetic acid chelating moiety with polyhydroxylated substituents |
DE102009053171B4 (de) | 2009-11-04 | 2011-07-21 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Verfahren zur Herstellung des Calcium-Komplexes von Dihydroxy-hydroxy-methylpropyl-tetraazacyclododecan-triessigsäure (Calcobutrol) |
WO2011054480A1 (de) | 2009-11-09 | 2011-05-12 | Bayer Schering Pharma Aktiengesellschaft | Gadobutrolherstellung mittels keramischer membran |
DE102009057274B4 (de) | 2009-12-02 | 2011-09-01 | Bayer Schering Pharma Aktiengesellschaft | Gadobutrolherstellung mittels Trioxobicyclo-octan |
EP2327395A1 (en) * | 2009-11-23 | 2011-06-01 | Bracco Imaging S.p.A | Process for the preparation of gadobenate dimeglumine complex in a solid form |
DE102010013833A1 (de) | 2010-03-29 | 2011-09-29 | Bayer Schering Pharma Aktiengesellschaft | Herstellung von Gadobutrol mittels Dimethylformamiddimethylacetal |
DE102010023105A1 (de) | 2010-06-04 | 2011-12-08 | Bayer Schering Pharma Aktiengesellschaft | Gadobutrolherstellung im Eintopfverfahren mittels DMF-acetal und N-Methylimidazol |
EP2457594A1 (en) | 2010-11-05 | 2012-05-30 | Bracco Imaging S.p.A | Cest systems exhibiting a concentration independent responsiveness |
NZ616637A (en) | 2011-04-21 | 2016-01-29 | Bayer Ip Gmbh | Preparation of high-purity gadobutrol |
SG11201804415QA (en) | 2015-12-10 | 2018-06-28 | Bracco Imaging Spa | Contrast agents |
DK3386954T3 (da) | 2015-12-10 | 2021-02-15 | Bracco Imaging Spa | Dimere kontrastmidler |
CN108779082B (zh) | 2016-04-13 | 2022-08-02 | 伯拉考成像股份公司 | 造影剂 |
SG11201901460UA (en) | 2016-09-27 | 2019-03-28 | Bayer Pharma AG | Method for producing the crystalline form of modification a of calcobutrol |
WO2018069176A1 (en) | 2016-10-12 | 2018-04-19 | T2Pharma Gmbh | Method of preparing formulations of lanthanide metal complexes of macrocyclic chelates |
WO2018069179A1 (en) | 2016-10-12 | 2018-04-19 | T2Pharma Gmbh | Method of preparing formulations of lanthanide metal complexes of macrocyclic chelates |
US10793533B2 (en) | 2016-12-12 | 2020-10-06 | Bracco Imaging S.P.A. | Dimeric contrast agents |
EP3392254A1 (en) * | 2017-04-20 | 2018-10-24 | Koninklijke Philips N.V. | Compounds for use in the diagnosis of a disease |
KR101971435B1 (ko) | 2017-08-29 | 2019-04-24 | 주식회사 엔지켐생명과학 | 가도부트롤 중간체 및 이를 이용한 가도부트롤의 제조 방법 |
EP4083026A1 (en) | 2018-07-10 | 2022-11-02 | Biophore India Pharmaceuticals Pvt. Ltd. | Process for the preparation of 2,2',2''-(10-((2r,3s)-1,3,4-trihydroxy butan-2-yl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl) triacetic acid and its complexes |
KR102167614B1 (ko) * | 2018-08-23 | 2020-10-19 | 에스티팜 주식회사 | 가도부트롤의 제조방법 |
CN114573521B (zh) * | 2020-12-01 | 2023-10-27 | 威智医药股份有限公司 | 一种钆布醇及其中间体的制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1491129A (en) * | 1975-06-04 | 1977-11-09 | Guerbet Sa | Iodo-benzene derivatives and an x-ray contrast medium containing them |
US4284620A (en) * | 1979-03-23 | 1981-08-18 | Mallinckrodt, Inc. | N-(2-Hydroxyethyl)-2,4,6-triiodo-3,5-bis-(2-keto-L-gulonamido)benzamide and radiological compositions containing same |
NO161560C (no) * | 1980-04-17 | 1989-09-06 | Univ California | Symmetriske trijodisoftaldiamid-derivater og roentgenkontrastmidler inneholdende disse. |
DE3150916A1 (de) * | 1981-12-18 | 1983-06-30 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | N-hydroxyaethylierte 2,4,6-trijodaminoisiophthalsaeure-bis- trihydroxybutylamide, deren herstellung und diese enthaltende roentgenkontrastmittel" |
US5059412A (en) * | 1984-06-04 | 1991-10-22 | The Dow Chemical Company | Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors |
MX174467B (es) * | 1986-01-23 | 1994-05-17 | Squibb & Sons Inc | 1,4,7-triscarboximetil-1,4,7,10-tetraazaciclodo decano substituido en 1 y compuestos analogos |
US4885363A (en) * | 1987-04-24 | 1989-12-05 | E. R. Squibb & Sons, Inc. | 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs |
DE3625417C2 (de) * | 1986-07-28 | 1998-10-08 | Schering Ag | Tetraazacyclododecan-Derivate |
IT1224416B (it) * | 1987-12-24 | 1990-10-04 | Bracco Ind Chimica Spa | Chelanti macrociclici e loro chelati |
AU660033B2 (en) * | 1991-05-23 | 1995-06-08 | Imarx Pharmaceutical Corp. | Liposoluble compounds for magnetic resonance imaging |
US5358704A (en) * | 1993-09-30 | 1994-10-25 | Bristol-Myers Squibb | Hepatobiliary tetraazamacrocyclic magnetic resonance contrast agents |
-
1990
- 1990-03-19 DE DE4009119A patent/DE4009119A1/de not_active Withdrawn
-
1991
- 1991-03-18 DE DE59105815T patent/DE59105815D1/de not_active Expired - Lifetime
- 1991-03-18 NZ NZ237461A patent/NZ237461A/en unknown
- 1991-03-18 NO NO911063A patent/NO179610C/no not_active IP Right Cessation
- 1991-03-18 DE DE2000175007 patent/DE10075007I2/de active Active
- 1991-03-18 PT PT97065A patent/PT97065B/pt not_active IP Right Cessation
- 1991-03-18 HU HU91874A patent/HU215964B/hu active Protection Beyond IP Right Term
- 1991-03-18 CA CA002038493A patent/CA2038493C/en not_active Expired - Lifetime
- 1991-03-18 ES ES91250081T patent/ES2074219T3/es not_active Expired - Lifetime
- 1991-03-18 AT AT91250081T patent/ATE124405T1/de not_active IP Right Cessation
- 1991-03-18 DK DK91250081.6T patent/DK0448191T3/da active
- 1991-03-18 EP EP91250081A patent/EP0448191B1/de not_active Expired - Lifetime
- 1991-03-18 JP JP3077058A patent/JP2968367B2/ja not_active Expired - Lifetime
- 1991-03-19 US US07/671,041 patent/US5980864A/en not_active Expired - Lifetime
- 1991-03-19 IL IL9759291A patent/IL97592A/en not_active IP Right Cessation
- 1991-03-19 FI FI911330A patent/FI109695B/sv active Protection Beyond IP Right Term
- 1991-03-19 AU AU73610/91A patent/AU647091B2/en not_active Expired
- 1991-03-19 IE IE90291A patent/IE67643B1/en not_active IP Right Cessation
-
1998
- 1998-03-10 HK HK98101937A patent/HK1002811A1/xx not_active IP Right Cessation
-
1999
- 1999-07-23 US US09/359,045 patent/US6399043B1/en not_active Expired - Fee Related
-
2001
- 2001-02-14 NO NO2001003C patent/NO2001003I1/no unknown
-
2002
- 2002-04-09 US US10/118,430 patent/US6951639B2/en not_active Expired - Fee Related
-
2005
- 2005-09-26 US US11/234,385 patent/US20060078503A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI109695B (sv) | Diagnostiska 1,4,7,10-tetraazacyklododekanbutyltrioler, deras användning som diagnostiska medel och förfarande för deras framställning | |
EP1931673B1 (en) | Compounds comprising short aminoalcohol chains and metal complexes for medical imaging | |
RU2073005C1 (ru) | Хелатное соединение металла | |
CN108368067B (zh) | 二聚造影剂 | |
JP4689775B2 (ja) | 低毒性の常磁性金属のキレート錯体 | |
US5417959A (en) | Functionalized aza-crytand ligands for diagnostic imaging applications | |
FI94758B (sv) | Makrocykliska föreningar, med en 3,6,9,15-tetra-azabicyklo/9.3.1/pentadekanstruktur, deras användning i NMR-, röntgen- eller radiodiagnostik användbara kompositoner, och sådana kompositioner | |
AU627451B2 (en) | Mesotetraphenylporphyrin complex compounds, process for their production and pharmaceutical agents containing them | |
SK283838B6 (sk) | Komplexy kaskádových polymérov, spôsob ich výroby a farmaceutický prostriedok tieto látky obsahujúci | |
JPH05214096A (ja) | 重合体化合物、nmr診断およびx線診断のための薬剤の製造法、この種の薬剤、製薬学的薬剤、重合体化合物の製造法および製薬学的薬剤の製造法 | |
CN109963838B (zh) | 二聚造影剂 | |
CA2615434A1 (en) | Perfluoroalkyl-containing complexes, process for their production as well as their use | |
US6083479A (en) | Contrast media for infarction and necrosis imaging | |
EP0717737B1 (en) | Chelants as contrast enhancing agents | |
WO2017178301A1 (en) | Contrast agents | |
KR20050105474A (ko) | 삼량체 거대고리 치환된 벤젠 유도체 | |
AU2006272025A1 (en) | Complexes containing perfluoroalkyl, method for the production and use thereof | |
KR101451446B1 (ko) | 퍼플루오르화 peg기를 갖는 금속 킬레이트, 그의 제조 방법, 및 그의 용도 | |
US5919431A (en) | 1,4,7,10-tetraazacyclododecane derivatives, their use, pharmaceutical agents containing these compounds and process for their production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
SPCF | Supplementary protection certificate application filed |
Spc suppl protection certif: L20030006 |
|
SPCG | Supplementary protection certificate granted |
Spc suppl protection certif: L207 Extension date: 20130226 |
|
PC | Transfer of assignment of patent |
Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT Free format text: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT |